
|Articles|June 1, 2004
Biotech company previews cutting edge dermatologic research
San Francisco - When Ivor Caro, M.D., now medical director of dermatology at Genentech Inc., joined the South San Francisco-based biotechnology company last year, he saw great potential for dermatology research.
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
Clinicians Weigh Topical Sequencing and Escalation in Complex Atopic Dermatitis Cases
2
Common Mistakes in Managing Hair Loss and Pigmentary Disorders
3
CSU With Biochemical C1 Inhibitor Deficiency: Case Report Raises Diagnostic Questions
4
Phase 3 STOP-HS Trials Highlight Promise of Oral JAK1 Inhibition for Moderate to Severe Disease
5











